Office of the Director, National Institutes of Health; Notice of Meeting, 10221-10222 [2022-03799]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 36 / Wednesday, February 23, 2022 / Notices
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Visual Neuroscience.
Date: March 28, 2022.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Brian H. Scott, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892, 301–
827–7490, brianscott@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Oral and Dental.
Date: March 29, 2022.
Time: 1:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892, (301) 496–
8551, ingrahamrh@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Arthritis, Connective Tissue and
Skin Sciences.
Date: March 31, 2022.
Time: 9:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Chee Lim, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4128, Bethesda, MD 20892,
(301) 435–1850, limc4@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics on
Mycology and Parasitology.
Date: March 31, 2022.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mohammad Samiul Alam,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 809D,
Bethesda, MD 20892, (301) 435–1199,
alammos@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Promoting a
Basic Understanding of Chemical Threats to
Skin.
Date: March 31, 2022.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
18:04 Feb 22, 2022
Jkt 256001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Chee Lim, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4128, Bethesda, MD 20892,
(301) 435–1850, limc4@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR21–061:
Cancer Research Workforce Diversity.
Date: March 31, 2022.
Time: 12:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Juraj Bies, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Rm. 4158, MSC 7806, Bethesda, MD
20892, 301–435–1256, biesj@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–19–
264: Imaging, Biomarkers and Digital
Pathomics for the Early Detection of
Premetastatic Aggressive Cancer.
Date: March 31, 2022.
Time: 12:30 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Eleni Apostolos Liapi, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, 301–867–5309, eleni.liapi@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 17, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–03822 Filed 2–22–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, March
18, 2022, 10:00 a.m. to March 18, 2022,
07:00 p.m., National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 which was
published in the Federal Register on
February 08, 2022, FR Doc 2122–02527,
V–87, Number 26, Page 7194.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
10221
Meeting is being amended to change
the Contact Person from James Li to
David Filpula, Ph.D., Scientific Review
Officer, Center for Scientific Review,
National Institutes of Health. The
meeting is closed to the public.
Dated: February 17, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–03820 Filed 2–22–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Advisory Committee on
Research on Women’s Health.
The meeting will be held as a virtual
meeting and open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
Name of Committee: Advisory Committee
on Research on Women’s Health.
Date: April 6, 2022.
Time: 9:30 a.m. to 4:30 p.m.
Agenda: Director’s Report; Presentation
from the Director of the National Heart, Lung,
and Blood Institute (NHLBI); Panel
discussing health disparities and COVID–19;
and Concept clearances for various programs.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Samia Noursi, Ph.D.,
Associate Director, Science Policy, Planning,
and Analysis, Office of Research on Women’s
Health, National Institutes of Health, 6707
Democracy Blvd., Room 402, Bethesda, MD
20892, 301–496–9472, samia.noursi@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meetings. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
E:\FR\FM\23FEN1.SGM
23FEN1
10222
Federal Register / Vol. 87, No. 36 / Wednesday, February 23, 2022 / Notices
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page: https://
orwh.od.nih.gov/, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: February 16, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–03799 Filed 2–22–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[1651–0100]
Petition for Remission or Mitigation of
Forfeitures and Penalties Incurred
(CBP Form 4609)
U.S. Customs and Border
Protection (CBP), Department of
Homeland Security.
ACTION: 30-Day notice and request for
comments; extension of an existing
collection of information.
AGENCY:
The Department of Homeland
Security, U.S. Customs and Border
Protection will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995 (PRA). The
information collection is published in
the Federal Register to obtain comments
from the public and affected agencies.
DATES: Comments are encouraged and
must be submitted (no later than March
25, 2022) to be assured of consideration.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:04 Feb 22, 2022
Jkt 256001
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Requests for additional PRA information
should be directed to Seth Renkema,
Chief, Economic Impact Analysis
Branch, U.S. Customs and Border
Protection, Office of Trade, Regulations
and Rulings, 90 K Street NE, 10th Floor,
Washington, DC 20229–1177, telephone
number 202–325–0056, or via email
CBP_PRA@cbp.dhs.gov. Please note that
the contact information provided here is
solely for questions regarding this
notice. Individuals seeking information
about other CBP programs should
contact the CBP National Customer
Service Center at 877–227–5511, (TTY)
1–800–877–8339, or CBP website at
https://www.cbp.gov/.
CBP
invites the general public and other
Federal agencies to comment on the
proposed and/or continuing information
collections pursuant to the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.). This proposed information
collection was previously published in
the Federal Register (Volume 86 FR
Page 67963) on November 30, 2021,
allowing for a 60-day comment period.
This notice allows for an additional 30
days for public comments. This process
is conducted in accordance with 5 CFR
1320.8. Written comments and
suggestions from the public and affected
agencies should address one or more of
the following four points: (1) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information will have
practical utility; (2) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
suggestions to enhance the quality,
utility, and clarity of the information to
be collected; and (4) suggestions to
minimize the burden of the collection of
information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of responses. The
comments that are submitted will be
summarized and included in the request
for approval. All comments will become
a matter of public record.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Overview of This Information
Collection
Title: Petition for Remission or
Mitigation of Forfeitures and Penalties
Incurred.
OMB Number: 1651–0100.
Form Number: CBP Form 4609.
Current Actions: Extension without
change.
Type of Review: Extension (without
change).
Affected Public: Individuals and
Businesses.
Abstract: CBP Form 4609, Petition for
Remission of Forfeitures and Penalties
Incurred, is completed, and filed with
the CBP FP&F Officer designated in the
notice of claim by individuals who have
been found to be in violation of one or
more provisions of the Tariff Act of
1930, or other laws administered by
CBP. Persons who violate the Tariff Act
of 1930, or other laws administered by
CBP, are entitled to file a petition
seeking remission or mitigation of a
fine, penalty, or forfeiture incurred
under these laws. This petition is
submitted on CBP Form 4609. The
information provided on this form is
used by CBP personnel as a basis for
granting relief from forfeiture or penalty.
CBP Form 4609 is authorized by 19
U.S.C. 1618 and provided for by 19 CFR
171.1. It is accessible at https://
www.cbp.gov/newsroom/publications/
forms?title=4609.
This collection of information applies
to members of the public who may not
be familiar with import procedures and
CBP regulations. It may also be used by
the importing and trade community
who are familiar with import
procedures and with the CBP
regulations.
Type of Information Collection: CBP
Form 4609.
Estimated Number of Respondents:
1,610.
Estimated Number of Annual
Responses per Respondent: 1.
Estimated Number of Total Annual
Responses: 1,610.
Estimated Time per Response: 14
minutes.
Estimated Total Annual Burden
Hours: 376.
Dated: February 17, 2022.
Seth D. Renkema,
Branch Chief, Economic Impact Analysis
Branch, U.S. Customs and Border Protection.
[FR Doc. 2022–03819 Filed 2–22–22; 8:45 am]
BILLING CODE P
E:\FR\FM\23FEN1.SGM
23FEN1
]]>Agencies
[Federal Register Volume 87, Number 36 (Wednesday, February 23, 2022)]
[Notices]
[Pages 10221-10222]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03799]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Advisory Committee
on Research on Women's Health.
The meeting will be held as a virtual meeting and open to the
public. Individuals who plan to view the virtual meeting and need
special assistance or other reasonable accommodations to view the
meeting, should notify the Contact Person listed below in advance of
the meeting. The meeting will be videocast and can be accessed from the
NIH Videocasting and Podcasting website (https://videocast.nih.gov/).
Name of Committee: Advisory Committee on Research on Women's
Health.
Date: April 6, 2022.
Time: 9:30 a.m. to 4:30 p.m.
Agenda: Director's Report; Presentation from the Director of the
National Heart, Lung, and Blood Institute (NHLBI); Panel discussing
health disparities and COVID-19; and Concept clearances for various
programs.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Samia Noursi, Ph.D., Associate Director, Science
Policy, Planning, and Analysis, Office of Research on Women's
Health, National Institutes of Health, 6707 Democracy Blvd., Room
402, Bethesda, MD 20892, 301-496-9472, [email protected].
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meetings. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
[[Page 10222]]
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://orwh.od.nih.gov/, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: February 16, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-03799 Filed 2-22-22; 8:45 am]
BILLING CODE 4140-01-P
